Clinical Trial

Carbon Monoxide Blood and DNA Biorepository

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this biorepository is to collect blood from patients at the time of CO poisoning and at follow-up visits months to years later. These samples can be used in the future to learn more about how CO damages the heart and brain and whether blood tests could predict which patients will have problems after CO poisoning.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2012-12-27; most recent amendment 2023-09-27.
Trial Details
NCT Number NCT01758653
Lead Sponsor Intermountain Health Care, Inc.
Conditions Carbon Monoxide Poisoning
Enrollment 300 participants
Start Date 2012-02
Primary Completion 2032-12 (estimated)
Study Completion 2032-12 (estimated)
Updated on ClinicalTrials.gov 2023-09-29